Literature DB >> 12018449

Calcium-sensing receptor A986S polymorphism in human rectal cancer.

G Speer1, K Cseh, K Mucsi, I Takács, O Dworak, G Winkler, R Szödy, A Tislér, P Lakatos.   

Abstract

BACKGROUND AND AIMS: In vivo and in vitro experiments show the protective role of calcium ions (Ca2+) against colorectal cancer. The calcium-sensing receptor (CaSR) detects extracellular Ca2+ concentration. An association between the CaSR A986S polymorphism and serum calcium in healthy adults has been reported. Subjects with AA genotype had lower serum concentrations of Ca2+ than other genotypes. The expression of erbB-2, epidermal growth factor receptor (EGFR), p53, and ras in colorectal cancer has been suggested to have diagnostic and prognostic significance. PATIENTS AND METHODS: We investigated the relationship between the CaSR A986S polymorphism and the expression of erbB-2, EGFR, p53, and ras as well as the UICC stage in 56 patients with rectal cancer.
RESULTS: The occurrence of the genotype AA was not different in cancer patients and in 112 controls. In the presence of the coexpression of major oncogenes, patients with genotype AA were in significantly higher UICC stages than in the case of AS genotype. During the follow-up period AA genotype showed a tendency for poor prognosis.
CONCLUSIONS: Our observation raises the possibility that genetic alterations of CaSR influence the pathogenesis of rectal cancer.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12018449     DOI: 10.1007/s003840100359

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN: 0179-1958            Impact factor:   2.571


  9 in total

Review 1.  Engendering biased signalling from the calcium-sensing receptor for the pharmacotherapy of diverse disorders.

Authors:  K Leach; P M Sexton; A Christopoulos; A D Conigrave
Journal:  Br J Pharmacol       Date:  2014-03       Impact factor: 8.739

2.  Genetic variation in the retinoid X receptor and calcium-sensing receptor and risk of colorectal cancer in the Colon Cancer Family Registry.

Authors:  Elizabeth T Jacobs; Maria E Martínez; Peter T Campbell; David V Conti; David Duggan; Jane C Figueiredo; Robert W Haile; Elizabeth C LeRoy; Jenny N Poynter; Patricia A Thompson; John A Baron
Journal:  Carcinogenesis       Date:  2010-06-17       Impact factor: 4.944

3.  Genetic variation in calcium-sensing receptor and risk for colon cancer.

Authors:  Linda M Dong; Cornelia M Ulrich; Li Hsu; David J Duggan; Debbie S Benitez; Emily White; Martha L Slattery; Bette J Caan; John D Potter; Ulrike Peters
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-10       Impact factor: 4.254

Review 4.  Genetic polymorphisms of CASR and cancer risk: evidence from meta-analysis and HuGE review.

Authors:  Sohyun Jeong; Jae Hyun Kim; Myeong Gyu Kim; Nayoung Han; In-Wha Kim; Therasa Kim; Jung Mi Oh
Journal:  Onco Targets Ther       Date:  2016-02-09       Impact factor: 4.147

5.  Alanine to Serine Variant at Position 986 of Calcium Sensing Receptor and Colorectal Cancer Risk.

Authors:  Reza Dabiri; Touraj Mahmoudi; Hamid Farahani; Hossein Nobakht; Mohammad Reza Zali
Journal:  Iran J Cancer Prev       Date:  2016-08-09

6.  Quantitative assessment of the clinical susceptibility of calcium-sensing receptor polymorphisms in cancer patients.

Authors:  Haohai Huang; Tao Li; Dan Liao; Zhu Zhu; Yong Dong
Journal:  Cancer Manag Res       Date:  2018-04-12       Impact factor: 3.989

7.  CASR rs1801725 polymorphism is associated with the risk and prognosis of colorectal cancer: A case-control study.

Authors:  Yu-E Diao; Qing Xu
Journal:  J Clin Lab Anal       Date:  2020-07-10       Impact factor: 2.352

8.  Association between CASR polymorphisms, calcium intake, and colorectal cancer risk.

Authors:  Kyee-Zu Kim; Aesun Shin; Jeongseon Kim; Ji Won Park; Sung Chan Park; Hyo Seong Choi; Hee Jin Chang; Dae Yong Kim; Jae Hwan Oh
Journal:  PLoS One       Date:  2013-03-28       Impact factor: 3.240

9.  Vitamin D receptor and calcium-sensing receptor polymorphisms and colorectal cancer survival in the Newfoundland population.

Authors:  Yun Zhu; Peizhong Peter Wang; Guangju Zhai; Bharati Bapat; Sevtap Savas; Jennifer R Woodrow; Ishor Sharma; Yuming Li; Xin Zhou; Ning Yang; Peter T Campbell; Elizabeth Dicks; Patrick S Parfrey; John R Mclaughlin
Journal:  Br J Cancer       Date:  2017-08-01       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.